SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary quarterly update sharply raised its revenue and gross-margin outlook on stronger AI-platform demand, driving a major after-hours rally. Many traders welcomed the improved outlook and anticipated further gains or short covering, while others questioned whether the momentum would hold given the companys volatile history and lingering trust concerns.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs quarterly results beat expectations, with rapid growth in its AI compute business and an aggressive buildout outlook driving strong enthusiasm. Traders are also debating whether the ambitious growth targets justify the valuation given heavy capital spending and uncertain execution.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly profit beat expectations, but softer forward guidance and a reduced advertising-revenue outlook have intensified concerns about slowing growth and weighed on the shares. Traders are debating whether the ad business and content strategy can revive momentum, with many bearish while some view the selloff as overdone and are buying the dip.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

A sharp, high-volume rebound has put WULF in focus, with traders crediting CEO Paul Pragers CNBC interview and his explanation of the companys powered-shell model: leasing data-center infrastructure and power rather than buying GPUs. Bulls see its AI/HPC contracts and buildout as differentiating it from debt-heavy neocloud peers, while skeptics call the move a relief bounce and remain concerned about financing, execution, and the broader sector selloff.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports RAP-219 Phase 2 trial in acute bipolar mania met its primary and secondary endpoints, drawing attention to the drugs potential beyond epilepsy. Traders are split: some view the results as validation of the pipeline, while others cite the modest placebo-adjusted benefit and higher agitation-related discontinuations as reasons for caution as the early gains faded.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCN is drawing attention amid a price rebound and breakout chatter, with bullish traders pointing to Zebecs reported payroll, card and network adoption, including its Stellar deployment. Skeptics counter that the token has struggled to sustain gains and say adoption must translate into stronger usage, volume and token demand.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Anticipation of Reddits upcoming quarterly results is driving discussion, with traders watching for evidence that ad growth and AI data licensing can support the stock. Bulls expect strong results to break its recent range, while bears point to insider selling, valuation concerns, and frustrating price action.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders react to Middle East shipping and infrastructure threats that raise fears of oil-supply disruptions. Bulls see the geopolitical risk premium supporting crude, while bears expect it to unwind if shipping flows normalize or peace talks progress, fueling debate over the funds volatile moves.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgicals strong Q3 earnings beat was met with a sharp selloff, as traders focused on the narrowed da Vinci procedure-growth outlook and planned pricing cuts that could pressure revenue per procedure. The community is split between calling the reaction an overdone sell-the-news move and viewing slower growth and the litigation settlement as reasons for caution.

Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight ETF

Invesco S&P 500 Equal Weight ETF

RSP is drawing attention for outperforming the cap-weighted S&P 500 as gains spread across more constituent stocks while mega-cap technology lagged. Traders view the strength as evidence of broader participation and rotation beyond tech, though some caution that the improvement may not last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Healthcare ETFs to Buy as JNJ Slips 6% Despite Q3 Earnings Beat 

Johnson & Johnson's Q3 earnings beat fails to prevent a 6% stock drop, but three healthcare ETFs offer diversified exposure to its growth potential. 

Execution of Pharma Tariffs Brings These ETFs Into Focus

Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Healthcare ETFs Are Looking Up: Here's Why 

Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.

PFE, MRK, SNY, MRNA In Focus As Trump Reportedly Eyes Executive Order On Vaccines And Autism

Equity

The order’s contents remain unclear, and timing could shift, Bloomberg reported, citing people familiar with the matter.


Will Generic Drug Tariffs Impact Pharma ETFs?

New U.S. tariffs on generic drugs could pressure drugmakers and influence pharmaceutical ETFs. Here's what investors should watch.

ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook

 Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure. 

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

iShares Trust - iShares U.S. Pharmaceuticals ETF

Bearish Sentiment

<ul class="summary-bullets"><li>Decades of rigorous scientific research have consistently found no causal connection between childhood vaccines and autism.</li><li>However, Robert F. Kennedy Jr., now Health and Human Services secretary, has been a central figure in the modern anti-vaccine movement for two decades.</li><li>In May, the administration ordered the Centers for Disease Control and Prevention and its vaccine advisory panel to review U.S. childhood vaccine recommendations and consider aligning them with other developed countries that use fewer routine shots.</li></ul>The Donald Trump administration is reportedly actively considering an executive order on vaccines and autism, with a possible move as early as the week ahead. &nbsp;The order’s contents remain unclear, and timing could shift, Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-08-06/trump-administration-considers-order-on-autism-and-vaccines">reported</a>, citing people familiar with the matter. According to the news platform’s sources, the options under discussion by officials include research efforts that cover both prospective studies and reviews of historical data.Any order casting doubt on vaccines or further curtailing recommendations could pressure shares of major manufacturers reliant on childhood and routine immunization revenue. Key names include Pfizer (PFE), Moderna (MRNA), BioNTech (BNTX), GSK (GSK), Sanofi (SNY), and Merck (MRK).While PFE, MRK, and SNY shares traded marginally lower after-hours at the time of writing, MRNA edged up 1.5%, likely due to the <a href="https://stocktwits.com/news-articles/markets/equity/mrna-stock-pares-gains-despite-fda-green-light-for-first-m-rna-flu-vaccine-but-retail-cheers-pivot-beyond-covid/cZoB5gXRJJQ">recent approval</a> of its flu vaccine on Wednesday.<h2 class="st-heading-2">The War Against Vaccines</h2>Decades of rigorous scientific research have consistently found no causal connection between childhood vaccines and autism.Robert F. Kennedy Jr., who serves as Health and Human Services secretary, has long been a leading voice in the modern anti-vaccine movement through his earlier leadership of Children’s Health Defense. In the current administration, he has overhauled a federal autism advisory panel by appointing members affiliated with organizations that advance unproven claims of vaccine-autism links, ordered research aimed at exploring such connections, and backed efforts to scale back the recommended childhood immunization schedule. &nbsp;President Donald Trump has voiced skepticism about vaccines for more than a decade, including assertions dating to the 2016 campaign and earlier that childhood immunizations contribute to autism. He has also repeated unsupported associations involving vaccines, acetaminophen use during pregnancy, and climbing autism diagnosis rates, while advising parents to space or postpone certain shots—even as he has stated that he remains in favor of vaccines overall. &nbsp;In May 2026, the administration issued an executive order directing the Centers for Disease Control and Prevention and its advisory committee to review an HHS assessment and realign the U.S. childhood vaccine schedule with practices in peer-developed countries that recommend fewer routine shots; earlier related moves faced court challenges.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around iShares U.S. Pharmaceuticals ETF, which holds major multinational vaccine producers alongside general drug manufacturers, rose from ‘bearish’ to ‘bullish’ over the past 24 hours, while retail chatter stayed at ‘low’ levels.<a href="https://stocktwits.com/symbol/IHE">IHE</a> has gained 21% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/dkng-stock-slips-after-hours-as-q2-earnings-disappoint-ceo-says-predictions-growing-faster-than-expected-ready-to-win-nfl-season/cZoBQgERJJs">DKNG Stock Slips After-Hours As Q2 Earnings Disappoint — CEO Says Predictions Growing Faster Than Expected, Ready To Win NFL Season</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. President Donald Trump speaks during a bilateral meeting at the Bestepe Presidential Compound, following Trump’s arrival to attend the annual NATO Summit on July 7, 2026 in Ankara, Turkey. (Photo by Win McNamee/Getty Images)

Decades of rigorous scientific research have consistently found no causal connection between childhood vaccines and autism.However, Robert F. Kennedy Jr., now Health and Human Services secretary, has been a central figure in the modern anti-vaccine moveme

Glaxosmithkline plc - ADR

iShares U.S. Pharmaceuticals ETF

Merck & Co Inc

Moderna Inc

Pfizer Inc

Sanofi-Aventis

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$103.47
Prev Close	$100.58
Open	$101.80
Dividend Yield	N/A
50-Day Moving Average	$102.41
Beta	N/A
Avg. Volume	152,403.01
PE Ratio	N/A

52-Week High	$108.66
52-Week Low	$73.76
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IHE Fundamentals